NCT00089284 Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL Status TERMINATED Phase PHASE1/PHASE2
NCT00086749 Effect of Tamoxifen on Breast Density in Premenopausal Women With Breast Cancer or High Risk for Breast Cancer Status COMPLETED Phase N/A
NCT00086723 In Vivo Angiostatin Generation Using Tissue Plasminogen Activator and Captopril in Treating Patients With Progressive Metastatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00085631 Cisplatin and Radiation Therapy With or Without Hyperthermia Therapy in Treating Patients With Cervical Cancer Status TERMINATED Phase PHASE3
NCT00084344 Effect of 4-Hydroxytamoxifen Gel on Breast Density, Salivary Sex Steroids, and Quality of Life in Premenopausal Women Status COMPLETED Phase NA
NCT00083044 Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy Status WITHDRAWN Phase N/A
NCT00073866 Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00064532 Serum Sex Hormone Levels and Subclinical Atherosclerosis - Ancillary to MESA Status COMPLETED Phase N/A
NCT00058292 Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE1
NCT00058266 Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical Prostatectomy Status TERMINATED Phase PHASE2
NCT00058188 Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation Status TERMINATED Phase PHASE3
NCT00058006 Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00057993 Trastuzumab and Exemestane in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer Status WITHDRAWN Phase PHASE2
NCT00057980 Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT00057967 Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome Status COMPLETED Phase PHASE2
NCT00006457 Oltipraz in the Prevention of Lung Cancer in People Who Smoke Status COMPLETED Phase PHASE1
NCT00006262 Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer Status TERMINATED Phase PHASE2